High-Dose Versus Conventional-Dose Continuous Venovenous Hemodiafiltration and Patient and Kidney Survival and Cytokine Removal in Sepsis-Associated Acute Kidney Injury: A Randomized Controlled Trial

American Journal of Kidney Diseases

Volumn 68, Issue 4, 2016, Pages 599-608

  Park, Jung Tak ^a   Kee, Youn Kyung ^a,d   Oh, Hyung Jung ^a   Han, Seung Hyeok ^a   Kang, Shin Wook ^a   Yoo, Tae Hyun ^a   Lee, Hajeong ^b   Park, Seokwoo ^b   Joo, Kwon Wook ^b,c   Lim, Chun Soo ^b,c   Kim, Yon Su ^b,c   Kim, Dongki ^b,c   Jo, Hyung Ah ^d   Han, Miyeun ^d   Lee, Sunhwa ^d   Kim, Eun Young ^d   Yang, Ji Soo ^d   Lee, Mi Jung ^d   Kwon, Young Eun ^d   Park, Kyoung Sook ^d   Han, Seung Gyu ^d   Kim, Hyung Woo ^d   Park, Seohyun ^d   Jung, Su Young ^d   Kim, Eun Kyoung ^d   Kim, Min Hee ^d   Kim, Yeon Ji ^d   Jang, Yoon Hee ^d   Kim, Mi Rae ^d   Song, Kwnag Ju ^d   Kim, Mi Ae ^d   Hyun, Ju Young ^d   Choi, Byeol Na ^d   more..

^a Yonsei University College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

^d NONE

Author keywords

acute kidney injury (AKI); continuous renal replacement therapy (CRRT); continuous venovenous hemodiafiltration (CVVHDF); CRRT intensity; CVVHDF dose; cytokine removal; immunomodulation; inflammatory cytokines; interleukins; randomized controlled trial; Sepsis; sepsis induced AKI; systemic inflammatory response syndrome

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATININE; CYTOKINE; HEMOGLOBIN; HEPARIN; INOTROPIC AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LACTIC ACID; MAGNESIUM; NAFAMSTAT MESILATE; PHOSPHATE; POTASSIUM; HEMODIALYSIS FLUID;

ACIDEMIA; ACUTE KIDNEY FAILURE; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ARTIFICIAL VENTILATION; CONTINUOUS HEMODIAFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSATE; ELECTROLYTE DISTURBANCE; FEMALE; GASTROINTESTINAL INFECTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERKALEMIA; HYPOKALEMIA; HYPOPHOSPHATEMIA; KIDNEY FUNCTION; LACTATE BLOOD LEVEL; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPEN STUDY; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SURVIVAL; TREATMENT DURATION; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; ACUTE KIDNEY INJURY; BLOOD; COMPARATIVE STUDY; COMPLICATION; HEMODIAFILTRATION; MIDDLE AGED; PROCEDURES; SURVIVAL RATE;

ACUTE KIDNEY INJURY; CYTOKINES; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS SOLUTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEPSIS; SURVIVAL RATE;

EID: 84964322511     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2016.02.049     Document Type: Article

References (39)

1. 1 Manns, M., Sigler, M.H., Teehan BP Continuous renal replacement therapies: an update. Am J Kidney Dis 32:2 (1998), 185–207.
2. 2 Mehta, R.L., Pascual, M.T., Soroko, S., et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int 66:4 (2004), 1613–1621.
3. 3 Douma, C.E., Redekop, W.K., van der Meulen, J.H., et al. Predicting mortality in intensive care patients with acute renal failure treated with dialysis. J Am Soc Nephrol 8:1 (1997), 111–117.
4. 4 Jones, C.H., Richardson, D., Goutcher, E., et al. Continuous venovenous high-flux dialysis in multiorgan failure: a 5-year single-center experience. Am J Kidney Dis 31:2 (1998), 227–233.
5. 5 Schwilk, B., Wiedeck, H., Stein, B., et al. Epidemiology of acute renal failure and outcome of haemodiafiltration in intensive care. Intensive Care Med 23:12 (1997), 1204–1211.
6. 6 Silvester, W., Bellomo, R., Cole, L., Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med 29:10 (2001), 1910–1915.
7. 7 Uchino, S., Kellum, J.A., Bellomo, R., et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294:7 (2005), 813–818.
8. 8 Brun, C., Munck, O., Lesions of the kidney in acute renal failure following shock. Lancet 272:6969 (1957), 603–607.
9. 9 Wan, L., Bellomo, R., Di Giantomasso, D., et al. The pathogenesis of septic acute renal failure. Curr Opin Crit Care 9:6 (2003), 496–502.
10. 10 Havasi, A., Borkan, S.C., Apoptosis and acute kidney injury. Kidney Int 80:1 (2011), 29–40.
11. 11 Ronco, C., Kellum, J.A., Bellomo, R., et al. Potential interventions in sepsis-related acute kidney injury. Clin J Am Soc Nephrol 3:2 (2008), 531–544.
12. 12 Zarjou, A., Agarwal, A., Sepsis and acute kidney injury. J Am Soc Nephrol 22:6 (2011), 999–1006.
13. 13 Heering, P., Morgera, S., Schmitz, F.J., et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 23:3 (1997), 288–296.
14. 14 Kellum, J.A., Johnson, J.P., Kramer, D., et al. Diffusive vs. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Crit Care Med 26:12 (1998), 1995–2000.
15. 15 Morgera, S., Slowinski, T., Melzer, C., et al. Renal replacement therapy with high-cutoff hemofilters: impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis 43:3 (2004), 444–453.
16. 16 Sanchez-Izquierdo, J.A., Perez Vela, J.L., Lozano Quintana, M.J., et al. Cytokines clearance during venovenous hemofiltration in the trauma patient. Am J Kidney Dis 30:4 (1997), 483–488.
17. 17 Sander, A., Armbruster, W., Sander, B., et al. Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF alpha plasma concentrations. Intensive Care Med 23:8 (1997), 878–884.
18. 18 Clark, E., Molnar, A.O., Joannes-Boyau, O., et al. High-volume hemofiltration for septic acute kidney injury: a systematic review and meta-analysis. Crit Care, 18(1), 2014, R7.
19. 19 Herrera-Gutierrez, M.E., Seller-Perez, G., Arias-Verdu, D., et al. A comparison of the effect of convection against diffusion in hemodynamics and cytokines clearance in an experimental model of septic shock. J Trauma Acute Care Surg 73:4 (2012), 855–860.
20. 20 Mariano, F., Fonsato, V., Lanfranco, G., et al. Tailoring high-cut-off membranes and feasible application in sepsis-associated acute renal failure: in vitro studies. Nephrol Dial Transplant 20:6 (2005), 1116–1126.
21. 21 Tolwani, A.J., Campbell, R.C., Stofan, B.S., et al. Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol 19:6 (2008), 1233–1238.
22. 22 Investigators RRTS, Bellomo, R., Cass, A., Cole, L., Finfer, S., Gallagher, M., Lo, S., et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361:17 (2009), 1627–1638.
23. 23 Network VNARFT, Palevsky, P.M., Zhang, J.H., O'Connor, T.Z., Chertow, G.M., Crowley, S.T., Choudhury, D., et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359:1 (2008), 7–20.
24. 24 Ratanarat, R., Brendolan, A., Piccinni, P., et al. Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care 9:4 (2005), R294–R302.
25. 25 Ronco, C., Bellomo, R., Homel, P., et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356:9223 (2000), 26–30.
26. 26 Zhang, P., Yang, Y., Lv, R., et al. Effect of the intensity of continuous renal replacement therapy in patients with sepsis and acute kidney injury: a single-center randomized clinical trial. Nephrol Dial Transplant 27:3 (2012), 967–973.
27. 27 Bone, R.C., Balk, R.A., Cerra, F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:6 (1992), 1644–1655.
28. 28 Bouman, C.S., Oudemans-Van Straaten, H.M., Tijssen, J.G., et al. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 30:10 (2002), 2205–2211.
29. 29 Bellomo, R., Baldwin, I., Cole, L., et al. Preliminary experience with high-volume hemofiltration in human septic shock. Kidney Int Suppl 66 (1998), S182–S185.
30. 30 Bottoms, G., Fessler, J., Murphey, E., et al. Efficacy of convective removal of plasma mediators of endotoxic shock by continuous veno-venous hemofiltration. Shock 5:2 (1996), 149–154.
31. 31 Grootendorst, A.F., van Bommel, E.F., van der Hoven, B., et al. High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 18:4 (1992), 235–240.
32. 32 Lee, P.A., Matson, J.R., Pryor, R.W., et al. Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 21:6 (1993), 914–924.
33. 33 Bellomo, R., Lipcsey, M., Calzavacca, P., et al. Early acid-base and blood pressure effects of continuous renal replacement therapy intensity in patients with metabolic acidosis. Intensive Care Med 39:3 (2013), 429–436.
34. 34 De Vriese, A.S., Colardyn, F.A., Philippe, J.J., et al. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 10:4 (1999), 846–853.
35. 35 Simmons, E.M., Himmelfarb, J., Sezer, M.T., et al. Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 65:4 (2004), 1357–1365.
36. 36 Claure-Del Granado, R., Macedo, E., Chertow, G.M., et al. Effluent volume in continuous renal replacement therapy overestimates the delivered dose of dialysis. Clin J Am Soc Nephrol 6:3 (2011), 467–475.
37. 37 Joannes-Boyau, O., Honore, P.M., Perez, P., et al. High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med 39:9 (2013), 1535–1546.
38. 38 Roberts, D.M., Liu, X., Roberts, J.A., et al. A multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics. Crit Care, 19, 2015, 84.
39. 39 Uchino, S., Fealy, N., Baldwin, I., et al. Continuous is not continuous: the incidence and impact of circuit “down-time” on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med 29:4 (2003), 575–578.